Literature DB >> 12000741

ADAM 12 protease induces adipogenesis in transgenic mice.

Nobuko Kawaguchi1, Xiufeng Xu, Rie Tajima, Pauliina Kronqvist, Christina Sundberg, Frosty Loechel, Reidar Albrechtsen, Ulla M Wewer.   

Abstract

ADAM 12 (meltrin-alpha) is a member of the ADAM (a disintegrin and metalloprotease) family. ADAM 12 functions as an active metalloprotease, supports cell adhesion, and has been implicated in myoblast differentiation and fusion. Human ADAM 12 exists in two forms: the prototype membrane-anchored protein, ADAM 12-L, and a shorter secreted form, ADAM 12-S. Here we report the occurrence of adipocytes in the skeletal muscle of transgenic mice in which overexpression of either form is driven by the muscle creatine kinase promoter. Cells expressing a marker of early adipogenesis were apparent in the perivascular space in muscle tissue of 1- to 2-week-old transgenic mice whereas mature lipid-laden adipocytes were seen at 3 to 4 weeks. Moreover, female transgenics expressing ADAM 12-S exhibited increases in body weight, total body fat mass, abdominal fat mass, and herniation, but were normoglycemic and did not exhibit increased serum insulin, cholesterol, or triglycerides. Male transgenics were slightly overweight and also developed herniation but did not become obese. Transgenic mice expressing a truncated form of ADAM 12-S lacking the prodomain and the metalloprotease domain did not develop this adipogenic phenotype, suggesting a requirement for ADAM 12 protease activity. This is the first in vivo demonstration that an ADAM protease is involved in adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000741      PMCID: PMC1850877          DOI: 10.1016/S0002-9440(10)61136-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  ADAMs: focus on the protease domain.

Authors:  R A Black; J M White
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

Review 3.  Obesity.

Authors:  P Björntorp
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

Review 4.  Obesity.

Authors:  M Rosenbaum; R L Leibel; J Hirsch
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

5.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Role of glucagon in maintenance of euglycemia in fed and fasted rats.

Authors:  C L Brand; P N Jørgensen; U Knigge; J Warberg; I Svendsen; J S Kristensen; J J Holst
Journal:  Am J Physiol       Date:  1995-09

7.  A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo.

Authors:  B J Gilpin; F Loechel; M G Mattei; E Engvall; R Albrechtsen; U M Wewer
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

8.  De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor.

Authors:  N Kawaguchi; K Toriyama; E Nicodemou-Lena; K Inou; S Torii; Y Kitagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

9.  Human ADAM 12 (meltrin alpha) is an active metalloprotease.

Authors:  F Loechel; B J Gilpin; E Engvall; R Albrechtsen; U M Wewer
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

Review 10.  Understanding adipocyte differentiation.

Authors:  F M Gregoire; C M Smas; H S Sul
Journal:  Physiol Rev       Date:  1998-07       Impact factor: 37.312

View more
  31 in total

1.  Metalloproteases and adipogenesis: a weighty subject.

Authors:  Jennifer Lilla; Dominique Stickens; Zena Werb
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 2.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 3.  Adipose tissue remodeling in pathophysiology of obesity.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

4.  Z-DNA-forming silencer in the first exon regulates human ADAM-12 gene expression.

Authors:  Bimal K Ray; Srijita Dhar; Arvind Shakya; Alpana Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

6.  Elevated urinary ADAM12 protein levels in lithium-treated bipolar patients.

Authors:  C Nadri; Y Bersudsky; R H Belmaker; G Agam
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

7.  The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.

Authors:  N Rocks; C Estrella; G Paulissen; F Quesada-Calvo; C Gilles; M M Guéders; C Crahay; J-M Foidart; P Gosset; A Noel; D D Cataldo
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

8.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

10.  Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice.

Authors:  Louise Helskov Jørgensen; Charlotte Harken Jensen; Ulla M Wewer; Henrik Daa Schrøder
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.